業績｜論文・出版物｜目次｜ALL

A dopamine antagonist, domperidone, enhances the replication of an oncolytic adenovirus in human tumor cells.

Nishimae F., Sakurai F., Ono R., Onishi R., Takayama K., Mizuguchi H.

J. Gen. Virol, 103, 1752 (2022)

ZFAND3 Overexpression in the Mouse Liver Improves Glucose Tolerance and Hepatic Insulin Resistance.

Shimizu K., Ogiya Y., Yoshinaga K., Kimura H., Michinaga .S, Ono M., Taketomi A., Terada T., Sakurai F., Mizuguchi H., Tomita K., Nishinaka T.

Exp. Clin. Endocrinol. Diabetes, 130, 254-261 (2022)

Adenovirus vector-based vaccine for infectious diseases.

Sakurai F., Tachibana M., Mizuguchi H.

Drug Metab. Pharmacokinet., 42, 100432 (2022)

Tumor-targeted fluorescence labeling systems for cancer diagnosis and treatment.

Tazawa H., Shigeyasu K., Noma K., Kagawa S., Sakurai F., Mizuguchi H., Kobayashi H., Imamura T., Fujiwara T.

Cancer Sci., 113, 1919-1929 (2022)

Oncolytic adenovirus serotype 35 mediated tumor growth suppression via efficient activation and tumor infiltration of natural killer cells

Ono R., Sakurai F., Tokuoka S., Ishii K., Mizuguchi H

BioRxiv (2022)

アデノウイルスベクターワクチンの現状と展望

水口裕之、立花雅史、櫻井文教

ドラックデリバリーシステム, 37, 421-428 (2022)

ヒト35型アデノウイルスを基本骨格とした腫瘍溶解性アデノウイルスの開発

櫻井文教、小野良輔、水口裕之

BIO Clinica, 37, 520-524 (2022)

アデノウイルスベクターワクチン設計のサイエンス　～COVID-19に対するワクチン開発を中心に～

水口裕之

別冊・医学のあゆみ, 83-88 (2022)

C型肝炎患者における薬剤治療の効果と耐性遺伝子変異の可能性

鳥羽由希子、

ファルマシア, 58, 361 (2022)

Generation of hepatocytes from human ES/iPS cells for regenerative medicine

Yamashita T., Takayama K., Mizuguchi H.

Springer Book: Cell-Inspired Materials and Engineering, Springer, 3-26 (2021)

WebSite

Development of a 3D Cell Culture System Using Amphiphilic Polydepsipeptides and Its Application to Hepatic Differentiation.

Enomoto J., Toba Y., Yamazaki H., Kanai M., Mizuguchi H., Matsui H.

ACS Applied Bio Materials., 4, 7290-7299 (2021)

WebSite

Oncolytic reovirus-mediated killing of mouse cancer-associated fibroblasts.

Kurisu N., Kaminade T., Eguchi M., Ishigami I., Mizuguchi H., Sakurai F.

Int. J. Pharmaceut, 610, 121269 (2021)

WebSite

Monolayer platform using human biopsy-derived duodenal organoids for pharmaceutical research

Yamashita T., Inui T., Yokota J., Kawakami K., Morinaga G., Takatani M., Hirayama D., Nomoto R., Ito K., Cui Y., Ruez S., Harada K., Kishimoto W., Nakase H., Mizuguchi H.

Mol. Ther. Methods Clin. Dev., 22, 263-278 (2021)

WebSite

miR-27b antagonizes BMP signaling in early differentiation of human induced pluripotent stem cells.

Lim J., Sakai E., Sakurai F., Mizuguchi H.

Sci. Rep., 11, 19820 (2021)

WebSite

Transduction properties of an adenovirus vector containing sequences complementary to a liver-specific microRNA, miR-122a, in the 3'-untranslated region of the E4 gene in human hepatocytes from chimeric mice with humanized liver.

Sakurai F., Tsukamoto T., Ono R., Nishimae F., Shiota A., Iizuka S., Shimizu K., Sakai E., Ishida Y., Tateno C., Chayama K., Mizuguchi H.

Biol. Pharm. Bull., 44, 1506-1513 (2021)

WebSite

Generation of Tetrafluoroethylene-Propylene Elastomer-Based Microfluidic Devices for Drug Toxicity and Metabolism Studies.

Sano E., Deguchi S., Matsuoka N., Tsuda M., Wang M., Kosugi K., Mori C., Yagi K., Wada A., Yamasaki S., Kawai T., Yodogawa M, Mizuguchi H., Nakazawa N., Yamashita F., Torisawa Y.S., Takayama K.

ACS omega, 6, 24859-24865 (2021)

WebSite

Usability of Polydimethylsiloxane-Based Microfluidic Devices in Pharmaceutical Research Using Human Hepatocytes.

Deguchi S., Tsuda M., Kosugi K., Sakamoto A., Mimura N., Negoro R., Sano E., Nobe T., Maeda K., Kusuhara H., Mizuguchi H., Yamashita F., Torisawa Y.S., Takayama K.

ACS Biomater. Sci. Eng., 7, 3648-3657 (2021)

WebSite

Comparison of culture media for human intestinal organoids from the viewpoint of pharmacokinetic studies.

Yokota J., Yamashita T., Inui T., Nomoto R., Kishimoto W., Nakase H., Mizuguchi H.

Biochem. Biophys. Res. Commun., 566, 115-122 (2021)

WebSite

A selective cytotoxic adenovirus vector for concentration of pluripotent stem cells in human pluripotent stem cell-derived neural progenitor cells.

Hirai T., Kono K., Sawada R., Kuroda T., Yasuda S., Matsuyama S., Matsuyama A., Koizumi N., Utoguchi N., Mizuguchi H., Sato Y.

Sci. Rep., 11, 11407 (2021)

WebSite

Generation of tetracycline-controllable CYP3A4-expressing Caco-2 cells by the piggyBac transposon system.

Ichikawa M., Akamine H., Murata M., Ito S., Takayama K., Mizuguchi H.

Sci. Rep., 11, 11670 (2021)

WebSite

目次に戻る

大阪大学大学院薬学研究科分子生物学分野

Laboratory of Biochemistry and Molecular Biology

Graduate School of Pharmaceutical Sciences, Osaka University

業績｜論文・出版物｜目次｜ALL